Lineage Cell Therapeutics, Inc. (LCTX): Price and Financial Metrics
LCTX Price/Volume Stats
| Current price | $0.59 | 52-week high | $1.61 |
| Prev. close | $0.57 | 52-week low | $0.48 |
| Day low | $0.55 | Volume | 715,200 |
| Day high | $0.59 | Avg. volume | 2,654,300 |
| 50-day MA | $0.63 | Dividend yield | N/A |
| 200-day MA | $0.90 | Market Cap | 129.47M |
LCTX Stock Price Chart Interactive Chart >
Lineage Cell Therapeutics, Inc. (LCTX) Company Bio
Lineage Cell Therapeutics, Inc. operates as a biotechnology company. The Company offers cell-based therapies and gene marker-based molecular diagnostics for diseases and degenerative conditions. Lineage Cell Therapeutics serves patients in the United States.
LCTX Price Returns
| 1-mo | 5.73% |
| 3-mo | -32.21% |
| 6-mo | -43.27% |
| 1-year | -42.72% |
| 3-year | -62.42% |
| 5-year | -37.88% |
| YTD | 17.41% |
| 2024 | -53.90% |
| 2023 | -6.84% |
| 2022 | -52.24% |
| 2021 | 39.20% |
| 2020 | 97.75% |
Loading social stream, please wait...